Trade Mark Journal No.2025/043 24 October 2025
WO0000001879992 (5)
Office of origin: United States of America
Date of International Registration:27 August 2025
Date of designation in the UK:
27 August 2025

International priority date claimed: 3 March 2025
(United States of America)
(99064092)
- Class 5
- Cells and biological preparations intended for medical and clinical use, namely, T cells which have undergone adaptations to combat diseases.
Nant Holdings IP, LLC
Representative: Michael J. McCue Womble Bond Dickinson (US) LLP, 3993 Howard Hughes Parkway, Suite 600, Las Vegas NV 89169, UNITED STATES OF AMERICA